US Health Secretary Robert F. Kennedy Jr. cancelled $500 million in funding for mRNA vaccine development, citing concerns over safety and efficacy. This impacts 22 projects targeting viruses like influenza and Covid-19. The decision has drawn sharp criticism from health experts who highlight the mRNA vaccines' role in combating the pandemic and their proven safety. Kennedy argues for a shift to alternative vaccine platforms, claiming mRNA vaccines can prolong pandemics. Experts counter that viruses mutate regardless of vaccination, and the funding cut could hinder future pandemic preparedness.

Prepared by Olivia Bennett and reviewed by editorial team.